Herein, seven novel anti-VCAM-1 monoclonal antibodies (mAbs) generated from phage display biopanning were tested using a series of in vitro models of cell recruitment to determine their potential utility for treating atherosclerosis. This evidence concerns the gene VCAM1 and atherosclerosis.